APA (7th ed.) Citation

FRHA, N., KJH, A., ME, M., C, F., JFFH, v. D., B, v. d. W., . . . BCH, v. d. W. (2025). Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept. Antibiotics (Basel, Switzerland), 14(12), . https://doi.org/10.3390/antibiotics14121283

Chicago Style (17th ed.) Citation

FRHA, Nurmohamed, et al. "Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept." Antibiotics (Basel, Switzerland) 14, no. 12 (2025). https://doi.org/10.3390/antibiotics14121283.

MLA (9th ed.) Citation

FRHA, Nurmohamed, et al. "Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept." Antibiotics (Basel, Switzerland), vol. 14, no. 12, 2025, https://doi.org/10.3390/antibiotics14121283.